Medication info
Dualset Tablet

Dualset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Jungheon Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Active

MFDS item code 200709529 · Notified 2007.08.16 · Insurance code 053300230

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesic effects. Patients with hepatic impairment Consider extending the dosing interval with caution in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older and adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Jungheon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used for the relief of acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesic effects. Patients with hepatic impairment Consider extending the dosing interval with caution in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older and adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may cause liver damage in individuals who regularly consume more than three alcoholic drinks daily, so consultation with a doctor or pharmacist is necessary. One of the main ingredients of this medication, acetaminophen, may very rarely cause serious skin reactions; therefore, if a rash or allergic symptoms appear after taking it, discontinue use immediately and consult a healthcare professional. Tramadol, included in this medication, may increase the risk of seizures if the recommended dosage is exceeded, and the risk can rise further when taken with certain antidepressants or narcotic analgesics. Though rare, serious allergic reactions that are life-threatening may occur while taking this medication; thus, sudden difficulty in breathing or skin reactions should be reported to medical personnel immediately. This medication may suppress breathing in patients with acute and severe bronchial asthma, so it should only be administered in a properly equipped environment. Concurrent use of this medication with alcohol or central nervous system depressants may lead to severe drowsiness, respiratory depression, or even coma, so it should be avoided unless directed by a physician. Patients with increased intracranial pressure or those with head injuries should exercise caution when taking this medication, as respiratory depression may worsen their condition. This medication may lead to dependence, similar to morphine, so long-term use should always keep in mind the potential for dependence and abuse. Patients with poor liver function or liver disease should consult healthcare professionals before using this medication to reduce the risk of liver damage. In particular, those who have a fast-acting genotype for the enzyme CYP2D6 must be careful, as the active ingredient of this medication may accumulate excessively, leading to severe respiratory depression. This medication should not be administered to children under 12 years of age or adolescents under 18 years of age who have undergone tonsillectomy or adenoidectomy, and use should be avoided in adolescents aged 12 to 18 years except in special cases. This medication can cause sleep apnea or hypoxia; thus, if these symptoms occur or worsen, consult medical professionals immediately to consider dose adjustment or discontinuation. Elderly patients or those at risk of hyponatremia should monitor the possibility of developing hyponatremia while taking this medication. There are several instances where this medication should not be administered, so individuals with hypersensitivity, those addicted to central nervous system drugs, patients with severe respiratory depression, and those with severe liver, kidney, or heart dysfunction, as well as nursing mothers, should not take it. Abrupt cessation during treatment may cause withdrawal symptoms, so the dosage should be reduced gradually according to the physician's instructions. This medication may cause drowsiness or dizziness during driving or operating machinery, and caution should be exercised, particularly when taken with alcohol or other CNS depressants. In case of overdose, serious side effects such as respiratory depression, seizures, or liver damage may occur, requiring immediate emergency treatment, and specialized detoxification treatment may be necessary. During the course of taking this medication, do not take other analgesics or medications containing acetaminophen, as interactions may increase the risk of side effects; inform healthcare personnel of all medications being taken.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, death, carbon dioxide retention, respiratory inhibition, reduced appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, dysesthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, sweating, urination disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased blood creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, muscular rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, high anion gap metabolic acidosis, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, worsening of migraine, involuntary muscle contractions, dyspnea, asthma, exertional dyspnea, cough, bronchitis, urinary retention, polyuria, abnormal renal function values, oliguria, rash, increased sweating, urticaria, dysphagia, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, reduced appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, constipation, dyspepsia, abdominal pain, dry mouth, diarrhea, hiccups, paralytic ileus, cholecystitis, abnormal renal function values, increased saliva, gastrointestinal bleeding, nausea, vertigo, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. Additionally, it is recommended to keep the medication at room temperature between 1 and 30 degrees Celsius, avoiding places that are too hot or too cold.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.